Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl versus remifentanil during adult orthotopic liver transplant surgery
IRCT20151012024493N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of fentanyl and remifentanil in hepatic disease (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Amount of postoperative analgesic medications during the first 72 hours after surgery. Started Feb 2023; status: completed.
02
Drugs
fentanylremifentanil
03
Conditions
hepatic disease
Beyond the preview
Go deeper on IRCT20151012024493N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151012024493N6.